Pathogen safety of Prolastin®

D. Pifat, W. Osheroff, J. Hotta, N. Roth, K. Cai, S. Petteway (Research Triangle Park, United States Of America)

Source: Annual Congress 2006 - Clinical pearls in bronchoscopic and thransthoracic procedures
Session: Clinical pearls in bronchoscopic and thransthoracic procedures
Session type: Electronic Poster Session
Number: 2986
Disease area: Respiratory infections

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
D. Pifat, W. Osheroff, J. Hotta, N. Roth, K. Cai, S. Petteway (Research Triangle Park, United States Of America). Pathogen safety of Prolastin®. Eur Respir J 2006; 28: Suppl. 50, 2986

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Post license safety of Prolastin®
Source: Eur Respir J 2006; 28: Suppl. 50, 518s
Year: 2006

Confirmed clinical safety and efficacy of grass allergen tablets
Source: Eur Respir J 2005; 26: Suppl. 49, 134s
Year: 2005

Linezolid: safety and efficacy monitoring
Source: Eur Respir J 2012; 39: 1275-1276
Year: 2012


Linezolid: safety and efficacy monitoring
Source: Eur Respir J 2012; 39: 1276-1277
Year: 2012


Tolerability of anti-infective N-chlortaurine inhaled with a smart-nebuliser
Source: International Congress 2018 – New therapies for respiratory infections: experimental and translational studies
Year: 2018




Dry powder inhaled ribavirin in healthy volunteers:  safety, tolerability, lung and systemic pharmacokinetics
Source: International Congress 2017 – From microbiology to clinical work
Year: 2017


Contamination and carry-over in clinical pharmacokinetic trials with aerosolized budesonide
Source: Annual Congress 2011 - Drug delivery and pharmacokinetics I
Year: 2011

Efficacy and safety of omalizumab in real-life practice in India
Source: Annual Congress 2012 - Asthma: risk factors and effect of anti-IgE
Year: 2012


Long-term safety and tolerability of umeclidinium/vilanterol and umeclidinium in COPD
Source: Annual Congress 2013 –Clinical trials of LAMAs, LABAs, MABAs and theophylline for asthma and COPD
Year: 2013

Pharmacokinetics (PK), safety and tolerability of abediterol and mometasone furoate fixed- and free-dose combinations in healthy subjects
Source: International Congress 2014 – Novel approaches and evidence for drug development in respiratory diseases
Year: 2014

On linezolid efficacy and tolerability
Source: Eur Respir J 2012; 39: 770-772
Year: 2012


Roflumilast and sildenafil in healthy male volunteers: Single-dose pharmacokinetic interactions, safety and tolerability
Source: Annual Congress 2010 - Drug delivery and pharmacokinetics II
Year: 2010

Safety and pharmacokinetics of nintedanib plus sildenafil in the INSTAGE trial
Source: International Congress 2019 – Treatment and prognosis of idiopathic interstitial pneumonia
Year: 2019


Comparison of the efficacy and safety of budesonide administered via Clickhaler® or Turbuhaler®
Source: Eur Respir J 2003; 22: Suppl. 45, 311s
Year: 2003

Safety and tolerability of aerosolized human alpha-1 antitrypsin (AAT): a phase Ia/Ib clinical study
Source: Annual Congress 2008 - Novel experimental approaches to understanding asthma and COPD II
Year: 2008


Efficacy and safety of Linezolid in pneumonias
Source: Eur Respir J 2002; 20: Suppl. 38, 420s
Year: 2002

Tolerability and pharmacokinetics of inhaled bimosiamose in healthy human volunteers
Source: Eur Respir J 2006; 28: Suppl. 50, 332s
Year: 2006

Efficacy, safety and tolerability of linezolid for the treatment of XDR-TB: a study in China
Source: Eur Respir J 2015; 45: 161-170
Year: 2015



Efficacy, safety and tolerability of linezolid for the treatment of XDR-TB: a study in China
Source: Eur Respir J 2016; 47:1591-1592
Year: 2016


Safety, tolerability, pharmacodynamics (PD) and pharmacokinetics (PK) of GSK573719 inhalation powder in healthy subjects
Source: Annual Congress 2011 - Drug delivery and pharmacokinetics II
Year: 2011